Ingredion Incorporated (INGR), a global provider of sweeteners, starches, and specialty food ingredients, has spent 2026 trading well below the highs it reached in the prior year. With shares recently changing hands around $104, the $130 mark stands out for two reasons: it sits just beneath the stock's 52-week high of $130.48, and it is the explicit price target assigned by Benchmark, one of the more optimistic firms covering the name. Reaching $130 would therefore mean reclaiming a former peak — a classic test of whether the prior high acts as durable resistance or a launching pad for renewed upside.
Ingredion is a value- and income-oriented stock. It trades at roughly 11 times trailing earnings per share (EPS) — a measure of how much investors pay for each dollar of profit — with a forward dividend yield near 3.2%. Revenue over the trailing twelve months was about $7.22 billion, and the company generated net income of roughly $592 million. The balance sheet is relatively conservative, with a debt-to-equity ratio near 0.4 and a healthy current ratio.
Operationally, results have been mixed. In its most recent quarter, adjusted EPS of $2.82 and revenue of $1.85 billion narrowly beat expectations, but adjusted operating income declined year over year amid margin pressure. Management reaffirmed full-year adjusted EPS guidance of $10.30 to $10.90, signaling stability rather than explosive growth.
Several factors support a move back toward $130. First, the Texture & Healthful Solutions segment has been a bright spot, growing about 7% with nine consecutive quarters of volume gains as consumers shift toward clean-label and sugar-reduction products. Second, the pending acquisition of Tate & Lyle — expected to close in 2027 — could add meaningful scale and roughly $130 million in annual run-rate synergies by 2030. Third, Ingredion's valuation remains undemanding relative to the broader consumer staples sector, and its dividend offers a cushion that can attract income-focused buyers during pullbacks.
The path to $130 is not without friction. Tapioca costs reportedly surged 40% year-to-date, pressuring near-term profitability in key product lines. The U.S./Canada and Latin America Food & Industrial Ingredients segments have shown weakness, prompting management to narrow guidance and trim the upper end of its outlook. Currency and economic volatility in emerging markets add further uncertainty. A $130 print would also require sustained earnings growth — and most analysts currently forecast only modest EPS expansion over the next year.
Wall Street's stance is decidedly cautious. The consensus rating is a "Hold," with an average 12-month price target near $121.50 and a range spanning roughly $108 to $150. Benchmark stands out with a $130 target, while others have pulled back: UBS raised its target only modestly to $108, Barclays trimmed to $118, and Oppenheimer downgraded the stock. The gap between the $121.50 consensus and the $130 target highlights that hitting the higher level would require Ingredion to exceed current Street expectations rather than merely meet them.
From a technical analysis perspective, the $130–$131 zone represents the most important resistance level, as it coincides with the stock's prior 52-week high. A decisive break above that area would signal a potential trend change, while repeated failures could reinforce it as a ceiling. On the downside, the $94–$96 range has provided a meaningful support level, roughly aligning with the 52-week low. Ingredion's longer-term trend structure remains constructive but has not yet recovered the momentum needed to challenge the highs.
Traders monitoring a potential move toward $130 may benefit from a systematic way to track shifting conditions. Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. These signals can help traders discover new opportunities, monitor existing positions, and identify emerging trends more efficiently. For those watching Ingredion's attempt to reclaim its prior high, such tools offer an additional layer of signal-based perspective.
A return to $130 is plausible but not imminent. Ingredion's low valuation, dividend support, specialty-ingredient growth, and the strategic Tate & Lyle deal provide a credible foundation for gradual appreciation. However, the target sits well above the $121.50 consensus and requires a reacceleration in profitability that has so far been elusive amid input-cost pressures and softness in core segments. Investors should monitor Texture & Healthful Solutions volume growth, the timing and execution of the Tate & Lyle acquisition, margin recovery, and whether shares can hold support near the $94–$96 zone. A decisive, sustained move above $130 would need to be driven by fundamentals, not just technical momentum.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, INGR has been loosely correlated with FLO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INGR jumps, then FLO could also see price increases.
| Ticker / NAME | Correlation To INGR | 1D Price Change % | ||
|---|---|---|---|---|
| INGR | 100% | -0.41% | ||
| FLO - INGR | 47% Loosely correlated | -2.79% | ||
| CAG - INGR | 46% Loosely correlated | -0.90% | ||
| KHC - INGR | 44% Loosely correlated | -0.68% | ||
| GIS - INGR | 43% Loosely correlated | -2.47% | ||
| MDLZ - INGR | 41% Loosely correlated | -0.28% | ||
More | ||||
| Ticker / NAME | Correlation To INGR | 1D Price Change % |
|---|---|---|
| INGR | 100% | -0.41% |
| Food: Major Diversified industry (63 stocks) | -5% Poorly correlated | -0.82% |